FDA: Mifepristone Suit Has Govt.-Wide Implications, Could Spur Doc Suits

If anti-abortion doctors succeed in getting FDA’s approval of the abortion pill mifepristone overturned in court, there could be widespread consequences for all other FDA decisions, including drug approvals, as well as for other federal agency decisions, FDA and the Justice Department warn in a statement filed with a U.S. district court in Texas on Wednesday (Jan. 18). The suit could open the door for doctors to sue over “virtually any FDA action” that they think affects their business or...